Literature DB >> 21732568

Ocular surface changes after lateral rectus muscle recession.

Sohee Jeon1, Shin Hae Park, Jun-Sub Choi, Sun Young Shin.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the changes in the integrated ocular surface/lacrimal gland unit after strabismus surgery. PATIENTS AND METHODS: The authors prospectively studied 23 patients undergoing lateral rectus muscle recession via fornix incision. At 1 week preoperatively and 1, 2, 3, and 4 months postoperatively, McMonnies' dry eye questionnaire, corneal fluorescein staining, corneal and conjunctival sensitivity with an esthesiometer, tear film break-up time, Schirmer I test, and impression cytology were performed. Impression cytology was performed in the inferotemporal and superotemporal bulbar conjunctiva and the goblet cell density (GCD) was measured.
RESULTS: McMonnies' dry eye questionnaire scores increased significantly after surgery (P < .05 at 7 days and 1, 2, and 3 months) and returned to baseline at 4 months postoperatively. A temporary increase in corneal staining was observed, but it returned to baseline by 2 months. The tear film break-up time score was decreased at 1 week postoperatively and recovered slowly, but did not return to normal by 4 months. GCD in the inferotemporal area was significantly decreased until 2 months postoperatively.
CONCLUSION: Tear film instability resulted from GCD depletion and conjunctival sensitivity could be one of the causative factors of ocular irritation symptoms after strabismus surgery. The ocular surface parameters returned to baseline at 4 months postoperatively. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732568     DOI: 10.3928/15428877-20110630-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  1 in total

1.  Ocular surface changes after strabismus surgery with different incisions.

Authors:  Qian Li; Te Fu; Jun Yang; Qiao-Ling Wang; Zhong-En Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-12       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.